Print Page  Close Window

SEC Filings

10-K
MYOKARDIA INC filed this Form 10-K on 03/08/2018
Entire Document
 

 

MYOKARDIA, INC.

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Collaboration and license revenue

 

$

22,500

 

 

$

39,199

 

 

$

14,199

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development, net

 

 

48,136

 

 

 

36,215

 

 

 

28,393

 

General and administrative

 

 

21,973

 

 

 

16,289

 

 

 

9,019

 

Total operating expenses

 

 

70,109

 

 

 

52,504

 

 

 

37,412

 

Loss from operations

 

 

(47,609

)

 

 

(13,305

)

 

 

(23,213

)

Interest and other income, net

 

 

1,657

 

 

 

153

 

 

 

(47

)

Change in fair value of redeemable convertible

   preferred stock call option liability

 

 

 

 

 

 

 

 

314

 

Net loss

 

 

(45,952

)

 

 

(13,152

)

 

 

(22,946

)

Other comprehensive (loss) income

 

 

(200

)

 

 

8

 

 

 

 

Comprehensive loss

 

 

(46,152

)

 

 

(13,144

)

 

 

(22,946

)

Cumulative dividend relating to redeemable convertible

   preferred stock

 

 

 

 

 

 

 

 

(5,151

)

Accretion of redeemable convertible preferred stock

   to redemption value

 

 

 

 

 

 

 

 

(98

)

Net loss attributable to common stockholders

 

$

(45,952

)

 

$

(13,152

)

 

$

(28,195

)

Net loss per share attributable to common stockholders,

   basic and diluted

 

$

(1.40

)

 

$

(0.48

)

 

$

(4.48

)

Weighted average number of shares used to compute net loss

   per share attributable to common stockholders, basic and diluted

 

 

32,832,514

 

 

 

27,475,792

 

 

 

6,292,800

 

 

The accompanying notes are an integral part of these Consolidated Financial Statements

 

 

 

F-4